Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid receptor type-1: breaking the dogmas
Arnau Busquets‐Garcia, Edgar Soria‐Gómez, Luigi Bellocchio, et al.
F1000Research (2016) Vol. 5, pp. 990-990
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

CB 1 and CB 2 Receptor Pharmacology
A­llyn C. Howlett, Mary E. Abood
Advances in pharmacology (2017), pp. 169-206
Open Access | Times Cited: 294
Astroglial CB1 Receptors Determine Synaptic D-Serine Availability to Enable Recognition Memory
Laurie M. Robin, José F. Oliveira da Cruz, Valentin Langlais, et al.
Neuron (2018) Vol. 98, Iss. 5, pp. 935-944.e5
Open Access | Times Cited: 218
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 59
The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution
Samuel D. Banister, Mark Connor
Handbook of experimental pharmacology (2018), pp. 191-226
Closed Access | Times Cited: 114
Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
María Rodríguez-Muñoz, Yara Onetti, Elsa Cortés‐Montero, et al.
Molecular Brain (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 104
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1188-1203
Closed Access | Times Cited: 97
The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins
Samuel D. Banister, Mark Connor
Handbook of experimental pharmacology (2018), pp. 165-190
Closed Access | Times Cited: 87
Molecular Mechanism and Cannabinoid Pharmacology
Lesley D. Schurman, Dai Lu, Debra A. Kendall, et al.
Handbook of experimental pharmacology (2019), pp. 323-353
Open Access | Times Cited: 73
Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review
Marco Koch
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 72
Deep Convolutional Generative Adversarial Network (dcGAN) Models for Screening and Design of Small Molecules Targeting Cannabinoid Receptors
Yuemin Bian, Junmei Wang, Jaden Jungho Jun, et al.
Molecular Pharmaceutics (2019) Vol. 16, Iss. 11, pp. 4451-4460
Closed Access | Times Cited: 64
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
Hery Chung, Angélica Fierro, C. David Pessoa‐Mahana
PLoS ONE (2019) Vol. 14, Iss. 7, pp. e0220025-e0220025
Open Access | Times Cited: 63
Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity
Ujendra Kumar, Sneha Singh
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2568-2568
Open Access | Times Cited: 53
CIRCE: Web-Based Platform for the Prediction of Cannabinoid Receptor Ligands Using Explainable Machine Learning
Nicola Gambacorta, Fulvio Ciriaco, Nicola Amoroso, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 18, pp. 5916-5926
Closed Access | Times Cited: 21
Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators
Sumanta Garai, Pushkar M. Kulkarni, Peter C. Schaffer, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 2, pp. 542-568
Open Access | Times Cited: 53
Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming
Alba Angelina, Mario Pérez‐Diego, Jacobo López‐Abente, et al.
Mucosal Immunology (2021) Vol. 15, Iss. 1, pp. 96-108
Open Access | Times Cited: 33
Endocannabinoid signaling in microglia
Sara Marinelli, Maria Cristina Marrone, Marina Di Domenico, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 71-90
Closed Access | Times Cited: 23
Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity
Valentina Castelli, Gianluca Lavanco, Salvatore Feo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 692-692
Open Access | Times Cited: 13
Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
David Chamoso‐Sánchez, Michela Panini, Clarissa Caroli, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway
Laís Mara Siqueira das Neves, Elaine Cristina Dalazen Gonçalves, Juliana Cavalli, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 7, pp. 5580-5593
Closed Access | Times Cited: 45
The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report)
Vincenzo Abbate, Michael Schwenk, Brandon C. Presley, et al.
Pure and Applied Chemistry (2018) Vol. 90, Iss. 8, pp. 1255-1282
Open Access | Times Cited: 44
Schizophrenia and depression, two poles of endocannabinoid system deregulation
María Rodríguez-Muñoz, Pilar Sánchez‐Blázquez, Luís F. Callado, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 12
Open Access | Times Cited: 43
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
Ken Soderstrom, Eman Soliman, Rukiyah Van Dross
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 40
Medical cannabis: Another piece in the mosaic of autoimmunity?
D. Katz, I. Katz, BS Porat‐Katz, et al.
Clinical Pharmacology & Therapeutics (2016) Vol. 101, Iss. 2, pp. 230-238
Closed Access | Times Cited: 39
Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use
Alison C. Burggren, Prabha Siddarth, Zanjbeel Mahmood, et al.
Cannabis and Cannabinoid Research (2018) Vol. 3, Iss. 1, pp. 242-251
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top